Peanut allergy breakthrough: daily doses could build tolerance
NCT ID NCT04222491
First seen Apr 28, 2026 · Last updated Jun 02, 2026 · Updated 9 times
Summary
This study looks at whether a treatment called oral immunotherapy (OIT) can help people with peanut allergy safely eat small amounts of peanut protein without having an allergic reaction. About 500 people aged 6 months to 65 years will gradually increase their peanut intake under medical supervision. The goal is to see if they can tolerate a maintenance dose of 300 mg peanut protein within two years, and whether their quality of life improves.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.